BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23563602)

  • 1. How to differentiate benign from malignant myometrial tumours using MR imaging.
    Thomassin-Naggara I; Dechoux S; Bonneau C; Morel A; Rouzier R; Carette MF; Daraï E; Bazot M
    Eur Radiol; 2013 Aug; 23(8):2306-14. PubMed ID: 23563602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle tumours of the uterus: MR imaging malignant predictive features-a 12-year analysis in a referral hospital in Portugal.
    Freitas P; Resende-Neves T; Lameira P; Costa M; Dias P; Filipe J; Ferreira J; Félix A; Cunha TM
    Arch Gynecol Obstet; 2024 Apr; 309(4):1551-1560. PubMed ID: 38055011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR Imaging Findings of Uterine Adenomatoid Tumors.
    Takeuchi M; Matsuzaki K; Bando Y; Harada M
    Magn Reson Med Sci; 2024 Apr; 23(2):127-135. PubMed ID: 36697028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study.
    Jacobs MA; Ouwerkerk R; Kamel I; Bottomley PA; Bluemke DA; Kim HS
    J Magn Reson Imaging; 2009 Mar; 29(3):649-56. PubMed ID: 19243047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas.
    Al Khuri M; Al Salmi I; Al Ajmi H; Al Hadidi A; Alabousi A; Haider E; Vasudev P; Al Salmi A; Jose S; Alrahbi N
    Int J Gynecol Cancer; 2024 Apr; ():. PubMed ID: 38658016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma.
    Sato K; Yuasa N; Fujita M; Fukushima Y
    Am J Obstet Gynecol; 2014 Apr; 210(4):368.e1-368.e8. PubMed ID: 24368137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
    Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted imaging (DWI) of adenomyosis and fibroids of the uterus.
    Jha RC; Zanello PA; Ascher SM; Rajan S
    Abdom Imaging; 2014 Jun; 39(3):562-9. PubMed ID: 24531353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.
    Lakhman Y; Veeraraghavan H; Chaim J; Feier D; Goldman DA; Moskowitz CS; Nougaret S; Sosa RE; Vargas HA; Soslow RA; Abu-Rustum NR; Hricak H; Sala E
    Eur Radiol; 2017 Jul; 27(7):2903-2915. PubMed ID: 27921159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
    Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
    Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
    Rio G; Lima M; Gil R; Horta M; Cunha TM
    Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas.
    Kubik-Huch RA; Weston M; Nougaret S; Leonhardt H; Thomassin-Naggara I; Horta M; Cunha TM; Maciel C; Rockall A; Forstner R
    Eur Radiol; 2018 Aug; 28(8):3125-3137. PubMed ID: 29492599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging.
    Sun S; Bonaffini PA; Nougaret S; Fournier L; Dohan A; Chong J; Smith J; Addley H; Reinhold C
    Diagn Interv Imaging; 2019 Oct; 100(10):619-634. PubMed ID: 31427216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?
    DeMulder D; Ascher SM
    AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-Weighted Imaging for Differentiating Uterine Leiomyosarcoma From Degenerated Leiomyoma.
    Li HM; Liu J; Qiang JW; Zhang H; Zhang GF; Ma F
    J Comput Assist Tomogr; 2017; 41(4):599-606. PubMed ID: 27997438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of atypical fibroids.
    Bolan C; Caserta MP
    Abdom Radiol (NY); 2016 Dec; 41(12):2332-2349. PubMed ID: 27826698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Process of Standardization of Diffusion-Weighted Imaging: Phantom Validation and Clinical Application According to the QIBA Profile.
    Choi SJ; Kim KW; Ko Y; Cho YC; Jang JS; Ahn H; Kim DW; Kim MY
    Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535004
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.
    Chen X; Guo Q; Chen X; Zheng W; Kang Y; Cao D
    BMC Med Imaging; 2024 Feb; 24(1):48. PubMed ID: 38373912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma.
    Toyohara Y; Sone K; Noda K; Yoshida K; Kato S; Kaiume M; Taguchi A; Kurokawa R; Osuga Y
    J Gynecol Oncol; 2024 May; 35(3):e24. PubMed ID: 38246183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.